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Abstract
Background: This study is to investigate the association of fibroblast growth factor receptor 2 (FGFR2) rs2981582,
trinucleotide-repeat-containing 9 (TNRC9) rs3803662, rs12443621, and leukocyte-specific protein 1 (LSP1) rs3817198
polymorphisms with breast cancer and mammographic density in Han Chinese population.
Methods: TaqMan Single Nucleotide Polymorphism (SNP) Genotyping Assays and unconditional logistic regression
analysis were used to examine these SNPs in 105 breast cancer cases and 382 controls.
Results: The genotype frequencies of rs12443621 and rs2981582 were significantly different between controls and
cases (P = 0.017 and 0.006, respectively). Subjects carrying G allele of rs12443621 had increased breast cancer risk
(AG vs AA: OR = 2.017, 95 % CI = 0.910–4.471; GG vs AA: OR = 2.684, 95 % CI = 1.318–5.463). Subjects carrying an
allele of rs2981582 had reduced breast cancer risk (GA vs GG: OR = 0.444, 95 % CI = 0.262–0.752; AA vs GG: OR =
0.579, 95 % CI = 0.342–0.983). rs3803662 and rs3817198 SNPs did not significantly differ between cases and controls
(P = 0.408 and 0.116, respectively). Interestingly, the AA genotype of rs2981582 was also associated with reduced
mammographic densities (P = 0.0092, 95 % CI = 0.334–0.926).
Conclusions: Our findings indicate that the GG genotype of rs12443621 is associated with increased breast cancer
risk whereas the GA and AA genotypes of rs2981582 are reduced risk in Han Chinese population.
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Background
Breast cancer is one of the most common malignancies
and a leading cause of cancer death in women world-
wide, with over one million new cases each year [1]. In
China, breast cancer has increased rapidly in recent
years and become the most common cancer for women
in major cities [2]. In Heilongjiang Province, which is lo-
cated in Northeast China, there are nearly 6000 new
cases of breast cancer every year accounting for 15 % of
female malignancies in the area [3]. Therefore, it is ne-
cessary to identify risk factors for breast cancer in this
Chinese population.
The development and progression of breast cancer is a
multi-step complicated process that involves both gen-
etic and epigenetic factors. Although significant ad-
vancement has been made in understanding the genetic
susceptibility to breast cancer, known susceptibility
genes account for less than a quarter of familial breast
cancer risk. To further identify novel susceptibility alleles
associated with breast cancer, genome-wide association
studies (GWAS) have been performed. One of these
studies was published on Nature [4], which identifies
trinucleotide-repeat-containing 9 (TNRC9), fibroblast
growth factor receptor 2 (FGFR2), mitogen-activated
protein kinase 1 (MAP3K1), and leukocyte-specific
protein 1 (LSP1) as four novel loci with consistent
evidence of association with breast cancer.
Since then, a number of case-control or cohort studies
have been carried out to further examine the association
of the single nucleotide polymorphisms (SNPs) with
breast cancer, but the results are not completely consist-
ent. For example, a cohort study in American population
found that the AG/GG genotypes of TNRC9 rs12443621
and the CT/TT genotype of FGFR2 rs2981582 had a de-
creased risk for death in breast cancer patients [5]. In
contrast, another cohort study in Swedish population
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found that the AG/GG genotypes of TNRC9 rs12443621
and the AA genotypes of FGFR2 rs2981582 both had
increased breast cancer risk [6]. A case-control study in
Tunisian population reported that subjects with AA
genotype of FGFR2 rs2981582 had increased risk of
breast cancer [7], but TNRC9 rs12443621 was not sig-
nificantly associated with breast cancer risk. Strong eth-
nic differences have been observed in breast cancer risk.
Racial/ethnic differences and environmental factors that
vary among populations may affect the associations be-
tween SNPs and risk of breast cancer by modulating
complex interactions between various genes. Therefore,
more studies are needed to clarify the relationship be-
tween these SNPs and breast cancer risk.
Mammographic density has been shown to be strongly
linked to breast cancer risk [8]. Women with high mam-
mographic density have increased risk for breast cancer
as compared to women with lower mammographic
density. Because both breast cancer and mammographic
density are influenced by genetic factors, they may share
some genetic determinants. A recent study showed that
women with at least one G allele of rs12443621 in TRC9
had higher mammographic density than women with
two alleles [9]. They also found that women with at least
one T allele of rs2981582 in FGFR2 had non-significantly
decreased mammographic density than women with
two C alleles.
To have a better understanding of the association of
FGFR2 rs2981582, TNRC9 rs3803662, rs12443621, and
LSP1 rs3817198 polymorphisms with breast cancer, we
investigated these SNPs in Han Chinese women in Hei-
longjiang Province and analyzed their association with
breast cancer risk and mammographic density.
Methods
Study population
All samples were collected at the First Affiliated Hospital
of Harbin Medical University in 2010 between June and
November. A total of 487 participants were recruited in
this study. The case group was comprised of 105 female
patients with histopathologically diagnosed breast can-
cer. Patients with a history of cancer, tumor chemother-
apy, or radiotherapy were excluded from this study. The
control group was comprised of 382 age-matched
healthy women. Ninety of the breast cancer cases and
229 of controls had mammographic X-ray. All subjects
gave written consent for participation in this research.
This study was approved by the Ethical Committee of
the First Hospital Affiliated to Haerbing Medical
University.
DNA extraction and TaqMan SNP Genotyping Assays
EDTA-anti-coagulated venous blood samples were pre-
served at −70 °C. Genomic DNA was isolated from
whole blood using the Wizard® kit (Promega, Madison,
WI, USA) according to the manufacturer’s protocol.
Blinded genotyping of FGFR2 rs2981582, TNRC9
rs3803662, rs12443621, and LSP1 rs3817198 was car-
ried out using TaqMan SNP Genotyping Assays (Ap-
plied Biosystems, Foster City, CA, USA) with Mini
Option2 Real Time PCR System (BioRad, Hercules,
California, USA). Assays were performed with TaqMan
Universal Master Mix, TaqMan probe, and 50 ng of
DNA per reaction. PCR conditions were provided by
the manufacturer: 5 min initial denaturation at 94 °C
followed by 45 cycles of 94 °C denaturation for 15 s
and 60 °C annealing/extension for 1 min.
Reproductive factors
Information on age, age at menarche, age at menopause,
breast-feeding, parity, and miscarriages/abortions was
assessed from the questionnaire. The number of miscar-
riages/abortions was categorized into three groups: 0,
1–2, and 3 or more.
Mammographic density
Mediolateral oblique (MLO) and craniocaudal (CC) view
digital mammograms were evaluated by three radiologists
specialized in mammographic diagnosis. Mammographic
density was described by using the Breast Imaging Report-
ing and Data System (BI-RADS, American College of
Radiology) four-category terminology [10]: D1, less than
25 % glandular (category 1), D2, 25–50 % glandular (cat-
egory 2), D3, 51–75 % glandular (category 3), and D4
greater than 75 % glandular (category 4). The evaluation
was blinded to ensure accuracy. For a few films on which
there was disagreement in reporting, final reporting was
made after the discussion among the radiologists.
Statistical analysis
Quantitative data were expressed as mean ± SD and ana-
lyzed using ANOVA or rank sum test. Categorical data
were analyzed using chi-square test. The association be-
tween the genotypes and breast cancer risk or mammo-
graphic density was evaluated by unconditional logistic
regression analysis and expressed as odds ratio (OR) and
their 95 % confidence intervals (CI) using SPSS 18.0
software (SPSS Inc., Chicago, IL, USA). Throughout the
analysis, a two-sided P value less than 0.05 was consid-
ered to be statistically significant.
Results
Distribution of TNRC9, FGFR2, and LSP1 SNPs in subjects
Using TaqMan SNP Genotyping Assays, we evaluated
FGFR2 rs2981582, TNRC9 rs3803662, TNRC9 rs12443621,
and LP1 rs3817198 polymorphisms in 487 subjects, includ-
ing 105 breast cancer cases and 382 controls. The genotype
frequencies for these SNPs in cases and controls and the
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allele frequencies in all subjects are listed in Table 1. All
four SNPs conformed to the Hardy-Weinberg equilibrium.
Reproductive factors and breast cancer risk
Reproductive characteristics of cases and controls are
summarized in Table 2. Case group had a significantly
younger age at menarche compared to control group (P =
0.022). Controls had longer average breast-feeding dur-
ation (0.000) and higher rate of breast-feeding history
(0.009). Controls also had a larger number of parity (0.03)
and higher rate of childbearing history compared to cases
(0.006). These factors were hence included in the multi-
variate analyses. All the other factors were similarly dis-
tributed between cases and controls.
TNRC9, FGFR2, and LSP1 SNPs and breast cancer risk
We examined the association between FGFR2 rs2981582,
TNRC9 rs3803662,TNRC9 rs12443621, and LP1 rs3817198
and breast cancer risk, and the results are shown in Table 1.
FGFR2 rs2981582 and TNRC9 rs12443621 genotype
frequencies were significantly different between case
and control groups (P = 0.006 and 0.017, respect-
ively). The AG and GG genotypes of rs12443621 in
TNRC9 were more prevalent among cases than
among controls (AG vs AA: OR = 2.017, 95 % CI = 0.910–
4.471; GG vs AA: OR = 2.684, 95 % CI = 1.318–5.463).
The GA and AA genotypes of rs2981582 in FGFR2 were
more prevalent among controls than among cases (GA vs
GG: OR = 0.444, 95 % CI = 0.262–0.752; AA vs GG: OR =
0.579, 95 % CI = 0.342–0.983). After adjusting for age and
reproductive risk factors, subjects carrying G allele of
rs12443621 in TNRC9 were found to have a higher breast
cancer risk compared with those carrying AA genotype
(AG vs AA: OR = 0.621, 95 % CI = 0.075–5.129; GG vs
AA: OR = 1.569, 95 % CI = 0.233–10.556).
TNRC9 rs3803662 and LSP1 rs3817198 genotype dis-
tribution in cases and controls was not significantly dif-
ferent (P = 0.408 and 0.116, respectively).
TNRC9, FGFR2, and LSP1 SNPs and mammographic
density
Analysis of mammographic density using rank sum test
showed a significant difference between cases and con-
trols (Table 3), with higher mammographic density in
case patients (χ2 = 4.4530, P = 0.0348). As shown in
Table 4, the distribution of FGFR2 rs2981582 poly-
morphism, but not the other three SNPs, was signifi-
cantly different among the four mammographic density
Table 1 Breast cancer risk in relation to selected SNPs
SNP Genotypes Cases Controls χ2a Pa ORa 95 % CIa Adjusted ORb 95 % CIb
TNRC9 AA 10 (11.2) 79 (18.8) 8.100 0.017 1.0 1.0
rs12443621 AG 24 (22.86) 94 (24.61) 2.017 0.910–4.471 0.621 0.075–5.129
GG 71 (67.62) 209 (54.71) 2.684 1.318–5.463 1.569 0.233–10.556
AG + GG 95 (90.48) 303 (79.32)
G allele 0.79 0.670
FGFR2 GG 50 (47.62) 120 (31.41) 10.203 0.006 1.0 1.0
rs2981582 GA 27 (25.71) 146 (38.22) 0.444 0.262–0.752 0.557 0.141–2.199
AA 28 (26.67) 116 (30.37) 0.579 0.342–0.983 0.559 0.154–2.032
GA + AA 55 (52.38) 262 (68.59)
A allele 0.395 0.495
TNRC9 CC 76 (72.38) 250 (65.44) 1.791 0.408 1.0 1.0
rs3803662 CT 21 (20) 96 (25.13) 0.720 0.420–1.232 0.304 0.075–1.241
TT 8 (7.61) 36 (9.42) 0.731 0.326–1.640 0.008 0.001–0.01
CT + TT 29 (27.62) 132 (34.56)
T allele 0.176 0.219
LSP1 TT 85 (80.95) 272 (71.20) 4.310 0.116 1.0 1.0
rs3817198 TC 18 (17.14) 93 (24.35) 0.619 0.354–1.085 0.059 0.159–2.183
CC 2 (1.90) 17 (4.45) 0.376 0.085–1.663 0.00 0.00–0.00
TC + CC 20 (19.05) 110 (28.80)
C allele 0.104 0.166
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categories (P = 0.0342). Subjects carrying AA genotype
of rs2981582 in FGFR2 were associated with reduced
mammographic density (Table 5, P = 0.0092, 95 % CI =
0.334–0.926). After adjusting for age and reproductive
risk factors, this remained significant (Table 6, P =
0.0154, 95 % CI = 0.294–0.893).
Discussion
In the present study, we found that early age at menar-
che is associated with increased breast cancer risk,
whereas breast-feeding and parity are associated with re-
duced breast cancer risk. Multiple studies have examined
the relationship between reproductive factors and breast
cancer risk, but the results are somewhat inconsistent. A
case-control study in Japanese population reported that
early age at menarche, late age at first birth, and pre-
menopausal status are significantly associated with
breast cancer risk, while high parity is a protective factor
[11]. A meta-analysis revealed that induced abortion is a
risk factor for breast cancer [12]. Stuver and coworkers
failed to observe any protective effects of lactation or
duration of lactation against breast cancer risk [13], al-
though there are other studies showing that lactation is
linked to reduced risk of breast cancer [14]. Breast can-
cer is a complicated disease affected by genetic, environ-
mental, and economic conditions as well as lifestyles.
Variations in these factors may contribute to the incon-
sistency in research findings on the association between
reproductive factors and breast cancer.
Our study revealed a significant association between
TNRC9 rs12443621 and breast cancer risk. Specifically,
the GG genotype of TNRC9 rs12443621 had increased
risk of breast cancer. The rs12443621 SNP of TNRC9
(also named TOX3) is located at chromosome 16q12
[4]. The function of TNRC9 is unclear, but a recent
paper has reported that TNRC9 down-regulates BRCA1
expression and promotes breast cancer aggressiveness
[7]. The association between TNRC9 polymorphisms
and breast cancer risk remains controversial. A meta-
analysis in 2011 found that TNRC9 rs3803662, but not
TNRC9 rs12443621, polymorphism was significantly cor-
related with breast cancer risk [15], which differs from
our results. However, our findings agree with a recently
published cohort study in Swedish population, which re-
ports an increased risk of breast cancer for subjects car-
rying AG/GG genotypes of TRNC9 rs12443621 [6]. The
reason for the inconsistency among published data re-
garding the association between TRNC9 rs12443621 and
breast cancer risk is hard to decipher but could be re-
lated to the multifaceted characteristics of breast cancer.
FGFR2 is a member of the FGFR family of receptor
tyrosine kinases that has been found to be overexpressed
in some breast cancer cell lines [16]. Amplification of
FGFR2 gene occurs in a small subset of breast cancer
[17]. Our study reveals an interesting finding that the
GA and AA genotypes of FGFR2 rs2981582 are associ-
ated with reduced risk of breast cancer. This is surpris-
ing, since most studies reported that the T allele of
FGFR2 rs2981582 is associated with increased breast
cancer risk [18, 19]. However, our results are consistent
with another case-control study in the Chinese popula-
tion, which also reveals the AA genotype of rs2981582
as a protective factor against breast cancer [20]. It is
worthwhile to mention that we also observed a strong
Table 3 Comparison of mammographic density between breast cancer cases and controls
Category 1 Category 2 Category 3 Category 4 Total χ2 P
Cases 8(8.89) 27(30.00) 51(56.67) 4(4.44) 90
Controls 8(3.49) 101(44.10) 114(49.78) 6(2.62) 229 4.453 0.035
Totals 16 128 165 10 319
Table 2 Comparison of age and reproductive factors between
breast cancer cases and controls
Cases (%) Control (%) P values χ2
Age 51.283 ± 11.29 49.91 ± 4.02 0.095 2.806
Age at menarche 14.53 ± 1.73 15.02 ± 1.99 0.022 5.291
Age at menopause 50.28 ± 4.14 49.07 ± 3.56 0.134 2.291
Breast-feeding (months) 9.03 ± 5.65 14.56 ± 11.71 0.000 34.31
No 25 (23.81) 50 (13.09) 0.009 6.895
Yes 80 (76.19) 332 (86.91)
Childbearing 0.006 7.487
No 9 (8.57) 13 (3.40)
Yes 96 (91.43) 369 (96.60)
Parity 0.03 6.641
0 9 (8.57) 1 (0.26)
1–2 93 (88.57) 345 (90.31)
≥3 3 (2.86) 24 (6.28)
Miscarriage/abortion 0.4 0.708
0 34 (32.38) 112 (29.31)
≥1 71 (7.62) 270 (70.68)
0 34 (32.38) 112 (29.32) 0.976 0.614
1–2 62 (59.05) 214 (56.02)
≥3 9 (8.57) 56 (14.66)
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association between the GA and AA genotypes of
FGFR2 rs2981582 and decreased mammographic dens-
ity. Meanwhile, our data showed that lower mammo-
graphic density is linked to lower risk of breast cancer.
These findings are consistent with each other. One limi-
tation of the current study was that the sample size for
breast cancer cases was relatively small (105 cases were
included in this study), and all patients were from Hei-
longjiang Province in Northeast China. We cannot rule
out the potential instability rising from a relatively small
number of patients. Further studies are necessary to
elude the reasons for the disparity between our results
and some of the earlier reports.
Conclusions
In conclusion, we detected a significant association
between the GG genotype of TNRC9 rs12443621 and
elevated breast cancer risk. Moreover, the GA and AA
genotypes of FGFR2 rs2981582 appear to be associated
with lower mammographic density and reduced breast
cancer risk. These data provide support for the poten-
tial importance of these polymorphisms in breast can-
cer biology. Further studies are needed to define the
role of these SNPs in breast cancer and test the possi-
bility of using them as biomarkers for diagnostic,
prognostic, or therapeutic purposes in Chinese Han
population.
Table 4 Mammographic density in relation to selected SNPs
SNP Genotype Mammographic density χ2 P
Category 1 Category 2 Category 3 Category 4 Total
TNRC9 AA 5(9.26) 27(50) 20(37.04) 2(3.70) 54 0.502 0.778
rs12443621 GG 7(3.83) 96(52.46) 74(40.44) 6(3.28) 183
AG 4(4.84) 42(51.22) 34(41.46) 2(2.44) 82
Total 16(5.02) 165(51.72) 128(40.13) 10(3.13) 319
FGFR2 GG 8(6.72) 71(59.66) 36(30.25) 4(3.36) 119 6.752 0.0342
rs2981582 GA 4(3.64) 53(48.18) 49(44.55) 4(3.64) 110
AA 4(4.44) 41(45.56) 43(47.78) 2(2.22) 90
Total 16(5.02) 165(51.72) 128(40.13) 10(3.13) 319
TNRC9 CC 14(6.45) 110(50.69) 85(39.17) 8(3.69) 217 1.1661 0.5582
rs3803662 CT 2(2.63) 38(50) 34(44.74) 2(2.63) 76
TT 0(0) 17(65.38) 9(34.62) 0(0) 26
Total 16(5.02) 165(51.72) 128(40.13) 10(3.13) 319
LSP1 TT 10(4.17) 128(53.33) 92(38.33) 10(4.17) 240 0.654 0.7211
rs3817198 CT 4(5.80) 33(47.83) 32(46.38) 0(0) 69
CC 2(20) 4(40) 4(40) 0(0) 10
Total 16(5.02) 165(51.72) 128(40.13) 10(3.13) 319
SNPs single nucleotide polymorphisms, TNRC9 trinucleotide-repeat-containing 9, FGFR2 fibroblast growth factor receptor 2, LSP1 leukocyte-specific protein 1
Table 5 Logistic regression analysis of the relationship between
mammographic density and selected SNPs
SNP Genotype P OR 95 % CI
AA 1.0
TNRC9 rs12443621 AG 0.4876 0.802 0.444–1.452
GG 0.7584 0.971 0.586–1.609
GG 1.0
FGFR2 rs2981582 GA 0.1929 1.022 0.596–1.751
AA 0.0092 0.556 0.334–0.926
CC 1.0
TNRC9 rs3803662 CT 0.4619 0.826 0.372–1.834
TT 0.3011 1.241 0.748–2.058
TT 1.0
LSP1 rs3817198 CT 0.3709 0.568 0.16–2.02
CC 0.4326 1.031 0.614–1.733
SNPs single nucleotide polymorphisms, TNRC9 trinucleotide-repeat-containing
9, FGFR2 fibroblast growth factor receptor 2, LSP1 leukocyte-specific protein 1,
OR odds ratio, CI confidence interval
Table 6 Logistic regression analysis of the relationship between
mammographic density and FGFR2 rs2981582 polymorphism
SNP Genotype P ORa 95 % CIa
GG 1.0
FGFR2 rs2981582 GA 0.4296 0.884 0.489–1.597
AA 0.0154 0.513 0.294–0.893
SNPs single nucleotide polymorphisms, FGFR2 fibroblast growth factor receptor
2, OR odds ratio, CI confidence interval
aAdjusted for age, age at menarche, age at menopause, breast-feeding, parity,
and miscarriage/abortions
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Abbreviations
CC: craniocaudal; CI: confidence intervals; FGFR2: fibroblast growth factor
receptor 2; GWAS: genome-wide association studies; LSP1: leukocyte-specific
protein 1; MAP3K1: mitogen-activated protein kinase 1; MLO: mediolateral
oblique; OR: odds ratio; SNPs: single nucleotide polymorphisms;
TNRC9: trinucleotide-repeat-containing 9.
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